Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela A Bota

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Biorxiv : the Preprint Server for Biology|June 9, 2023
Cisplatin Induces BDNF Downregulation in Middle-Aged Female Rat Model while BDNF Enhancement Attenuates Cisplatin NeurotoxicityNaomi Lomeli, Diana C Pearre, Maureen Cruz, et al.
Human Vaccines & Immunotherapeutics|January 28, 2015
The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patientsMichelle Paff, Daniela Alexandru-Abrams, Frank P K Hsu, et al.
CNS Spectrums|April 28, 2006
The dynamics of insight in the prodrome of schizophreniaRobert G Bota, J Stuart Munro, Walter F Ricci, et al.
Psycho-Oncology|October 11, 2025
Understanding the Trajectory of Depressive Symptoms in Newly Diagnosed High-Grade Glioma Patients-A Meta-AnalysisShayda M Abazari, Peter G Bota, Thomas H Taylor, et al.
Cancer|March 30, 2011
Pulmonary metastases in patients with recurrent, treatment-resistant meningioma: prognosis and identification by ¹¹¹Indium-octreotide imagingDaniela Alexandru, Michael J Glantz, Lyndon Kim, et al.
Mitochondrion|February 12, 2020
Mitochondrial-associated impairments of temozolomide on neural stem/progenitor cells and hippocampal neuronsNaomi Lomeli, Kaijun Di, Diana C Pearre, et al.
Oncotarget|October 21, 2016
Mitochondrial Lon is over-expressed in high-grade gliomas, and mediates hypoxic adaptation: potential role of Lon as a therapeutic target in gliomaKaijun Di, Naomi Lomeli, Spencer D Wood, et al.
Journal of the Advanced Practitioner in Oncology|February 2, 2023
Adherence to Prophylactic Anticonvulsant Guidelines for Newly Diagnosed Brain Tumor Patients: A Quality Improvement StudyDan Beverly Fu, Xiao-Tang Kong, Tener Goodwin Veenema, et al.
Antioxidants (Basel, Switzerland)|April 29, 2025
Neuronal p38 MAPK Signaling Contributes to Cisplatin-Induced Peripheral NeuropathyYugal Goel, Donovan A Argueta, Kristen Peterson, et al.
Clinical & Developmental Immunology|March 26, 2011
Immunotherapy of brain cancers: the past, the present, and future directionsLisheng Ge, Neil Hoa, Daniela A Bota, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Biorxiv : the Preprint Server for Biology|June 9, 2023
Cisplatin Induces BDNF Downregulation in Middle-Aged Female Rat Model while BDNF Enhancement Attenuates Cisplatin NeurotoxicityNaomi Lomeli, Diana C Pearre, Maureen Cruz, et al.
Human Vaccines & Immunotherapeutics|January 28, 2015
The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patientsMichelle Paff, Daniela Alexandru-Abrams, Frank P K Hsu, et al.
CNS Spectrums|April 28, 2006
The dynamics of insight in the prodrome of schizophreniaRobert G Bota, J Stuart Munro, Walter F Ricci, et al.
Psycho-Oncology|October 11, 2025
Understanding the Trajectory of Depressive Symptoms in Newly Diagnosed High-Grade Glioma Patients-A Meta-AnalysisShayda M Abazari, Peter G Bota, Thomas H Taylor, et al.
Cancer|March 30, 2011
Pulmonary metastases in patients with recurrent, treatment-resistant meningioma: prognosis and identification by ¹¹¹Indium-octreotide imagingDaniela Alexandru, Michael J Glantz, Lyndon Kim, et al.
Mitochondrion|February 12, 2020
Mitochondrial-associated impairments of temozolomide on neural stem/progenitor cells and hippocampal neuronsNaomi Lomeli, Kaijun Di, Diana C Pearre, et al.
Oncotarget|October 21, 2016
Mitochondrial Lon is over-expressed in high-grade gliomas, and mediates hypoxic adaptation: potential role of Lon as a therapeutic target in gliomaKaijun Di, Naomi Lomeli, Spencer D Wood, et al.
Journal of the Advanced Practitioner in Oncology|February 2, 2023
Adherence to Prophylactic Anticonvulsant Guidelines for Newly Diagnosed Brain Tumor Patients: A Quality Improvement StudyDan Beverly Fu, Xiao-Tang Kong, Tener Goodwin Veenema, et al.
Antioxidants (Basel, Switzerland)|April 29, 2025
Neuronal p38 MAPK Signaling Contributes to Cisplatin-Induced Peripheral NeuropathyYugal Goel, Donovan A Argueta, Kristen Peterson, et al.
Clinical & Developmental Immunology|March 26, 2011
Immunotherapy of brain cancers: the past, the present, and future directionsLisheng Ge, Neil Hoa, Daniela A Bota, et al.
Pageof 9